Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma, Kaposi 7HIV Infections 7Acquired Immunodeficiency Syndrome 7Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Dendritic Cell Sarcoma, Interdigitating 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Gliosarcoma 1Glioblastoma 1Desmoid Tumors 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Temozolomide 128Radiotherapy 85Bevacizumab 43Radiation 30Carmustine 29Irinotecan 25Erlotinib Hydrochloride 22Magnetic Resonance Spectroscopy 21Chemotherapy, Adjuvant 20Surgical Procedures, Operative 15O(6)-benzylguanine 15Carboplatin 14sargramostim 12Radiotherapy, Intensity-Modulated 12Radiotherapy, Conformal 12Sirolimus 10Imatinib Mesylate 9Filgrastim 9Drug Therapy 9temsirolimus 8pembrolizumab 8Thalidomide 8Sorafenib 8Radiosurgery 8Gefitinib 8motexafin gadolinium 7aldesleukin 7Procarbazine 7Gene Expression Profiling 7Cyclophosphamide 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Bleomycin × Sarcoma × Clear all
NCT00006916 2020-10-26

Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Radiation Therapy Oncology Group

Phase 2 Terminated
19 enrolled 4 charts
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡